Coronary interventions
Second-generation drug-eluting absorbable metal scaffold target-lesion revascularization: an optical coherence tomography case series study and literature review September 3, 2019 | 10.4244/EIJ-D-19-00421
Showing 1-8 of 8 articles
Coronary interventions
A randomized comparison of the coronary vasomotor function and myocardial flow in patients treated with everolimus-eluting bioresorbable scaffolds and everolimus-eluting metallic stents. June 18, 2019 | 10.4244/EIJ-D-18-01203
Coronary interventions
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study May 20, 2019 | 10.4244/EIJ-D-18-00504
STEMI
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial March 20, 2018 | 10.4244/EIJ-D-17-00608
Data from real-world registries: can it guide development of the bioresorbable scaffolds of tomorrow?
December 20, 2017 | 10.4244/EIJV13I11A197
Coronary interventions
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial August 4, 2017 | 10.4244/EIJ-D-16-00512
Coronary interventions
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score April 20, 2017 | 10.4244/EIJ-D-16-00974
